pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,356 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 18 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,356
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06069973: Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia

    Sponsor: Sahlgrenska University Hospital. Phase: . Conditions: Ischemic Stroke, Hemorrhagic Stroke

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07422727: Impact of Cooling Mats on Vasomotor Symptoms in Patients Receiving Endocrine Therapy

    Sponsor: Sligo General Hospital. Phase: NA. Conditions: Hot Flashes, Sleep, Hormonal, Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07458061: Kamuvudine-9 (K9) in Diabetic Macular Edema

    Sponsor: Dr. Bryan Strelow. Phase: PHASE1. Conditions: Diabetic Macular Edema

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07408661: Application of Artificial Intelligence and Iron Metabolism Markers in Predicting ICU Outcomes for Critically Ill Cancer Patients

    Sponsor: Tongji University. Phase: . Conditions: Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02811861: Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

    Sponsor: Eisai Inc.. Phase: PHASE3. Conditions: Renal Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05947279: Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation

    Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Motor Adaptation and Generalization, Posterior Parietal Cortex, Cerebellum

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06161480: Feasibility and Acceptability of Using Weighted Blankets to Prevent and /or Mitigate Delirium

    Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Delirium

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01164462: Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)

    Sponsor: French National Agency for Research on AIDS and Viral Hepatitis. Phase: NA. Conditions: HIV Infections

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07175662: Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

    Sponsor: Newish Biotech (Wuxi) Co., Ltd.. Phase: PHASE2. Conditions: High-grade Squamous Intraepithelial Lesion (HSIL)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05613088: A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Neoplasms, Ovarian

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07290179: Evaluating the Validity and Feasibility of a Smartwatch-based Eating Detection System to Passively and Automatically Detect Eating Events in Child-parent Dyads

    Sponsor: Pennington Biomedical Research Center. Phase: . Conditions: Eating Behavior

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07386379: Propofol Infusion and PONV in Cardiac Surgery

    Sponsor: Istanbul University - Cerrahpasa. Phase: . Conditions: Postoperative Nausea and Vomiting, Cardiovascular Surgical Procedures

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07327996: Evaluation of Pain Relief and Bacterial Reduction After Using Calcium Hydroxide With Mesoporous Silica Nanoparticles as an Intracanal Medicament in Necrotic Mandibular Molars: A Randomized Controlled Clinical Trial

    Sponsor: Future University in Egypt. Phase: NA. Conditions: Necrotic Pulp

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06995703: Increasing Screening for Cancer Using EHR-Nudges Replication

    Sponsor: Abramson Cancer Center at Penn Medicine. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07504003: Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise

    Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Endurance Exercise, Healthy Volunteers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07226661: Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    Sponsor: Supernus Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03897361: Stem Cell Gene Therapy for Cystinosis

    Sponsor: University of California, San Diego. Phase: PHASE1. Conditions: Lysosomal Storage Diseases, Cystinosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06675461: Brief Psychological Intervention for Suicidal Patients With Borderline Personality Disorder in the Emergency Department

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Borderline Personality Disorder (BPD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT04763161: Immuno-inflammation in the Acute Phase of an Ischaemic Cerebral Accident Managed by Decompressive Hemicraniectomy: a Case-control Study

    Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: . Conditions: Ischemic Cerebrovascular Accident

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06698003: A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: T-Cell Leukemia/Lymphoma, Adult, T-cell Leukemia/Lymphoma, T-cell Leukemia, Lymphoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07050927: Long-Term Effect of Online Occupational Therapy-Based Parent Training on Feeding Problems in Infants

    Sponsor: Ankara Medipol University. Phase: NA. Conditions: Feeding Difficulties, Feeding Problems, Food Neophobia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07542561: AI-Assisted Mindfulness Intervention in Emotional Distress

    Sponsor: Xinghua Liu. Phase: NA. Conditions: Subclinical Depression, Subclinical Anxious Adults, Subclinical Emotional Distress

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06512961: Applicability of Tissue Flossing for Blood Flow Restriction in the Upper Limb: Reliability and Performance Analysis

    Sponsor: Paulista University. Phase: NA. Conditions: Hypertrophy, Muscle Strength

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06480461: A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease

    Sponsor: Shanghai Vitalgen BioPharma Co., Ltd.. Phase: PHASE1. Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT06709261: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07333742: A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

    Sponsor: LG Chem. Phase: PHASE1. Conditions: Fed Conditions, Healthy Volunteer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07258303: Oral-Spray Bacillus Spore Probiotics for Periodontal Disease Prevention and Supprotive Treatment in the Elderly

    Sponsor: Anabio R&D. Phase: NA. Conditions: Periodontal Disease, Oral Deseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07555561: Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

    Sponsor: Beijing Boren Hospital. Phase: PHASE1. Conditions: Relapsed/Refractory Central Nervous System Lymphoma, Relapsed/Refractory Primary Central Nervous System Lymphoma, Relapsed/Refractory Secondary Central Nervous System Lymphoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07476742: Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium and Negative Emotions in Patients Undergoing Cardiac Surgery

    Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Postoperative Delirium (POD), Postoperative, Anxiety, Depression, Cardiac Surgical Procedures

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07479342: The Effect of Modern Teaching Method: Gamification in Orthodontics

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Gamification in Health Education

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07558642: Effects of Stellate Ganglion Block on Delirium and Circadian Rhythm in Geriatric Intensive Care Patients

    Sponsor: Antalya Training and Research Hospital. Phase: NA. Conditions: Stellate Ganglion Block

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05610527: Hormonal Influences on Inflammatory Bowel Diseases

    Sponsor: University of Utah. Phase: . Conditions: Inflammatory Bowel Diseases, Contraception, Menstrual Problem

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07027527: An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

    Sponsor: Apogee Therapeutics, Inc.. Phase: PHASE1. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07526688: Aerobic Physical Activity and Orofacial Myofascial Pain

    Sponsor: University Hospital, Brest. Phase: NA. Conditions: Temporomandibular Disorders (TMD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07181161: Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Metastatic Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07404761: Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments

    Sponsor: Motion Informatics LTD. Phase: NA. Conditions: Stroke, Upper-limb Motor Impairment, Hemiparesis, Spinal Cord Injury, Traumatic Brain Injury

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04214561: Relationship Between Selected Parameters and Bruxism

    Sponsor: Wroclaw Medical University. Phase: . Conditions: Sleep Bruxism, Sleep Disorder, Psychosomatic Disorder, Pain, Anxiety, Mental Status Change, Temporomandibular Disorder

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05468203: PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care

    Sponsor: The George Institute. Phase: PHASE3. Conditions: Acute Kidney Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07437703: Labour Pain Relief Options: Video Versus Pamphlet for Easing Fear of Birth and Improving Preparedness in Pregnant Patients, an RCT

    Sponsor: Fraser Health. Phase: NA. Conditions: Labour Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06152627: Voice Therapy Per the Rehabilitation Treatment Specification System

    Sponsor: Massachusetts General Hospital. Phase: . Conditions: Muscle Tension Dysphonia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04953442: Fit 24 Technology Intervention YOUTH

    Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05202288: Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

    Sponsor: ANRS, Emerging Infectious Diseases. Phase: PHASE2. Conditions: Ebola Virus Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07557888: A Prospective Clinical Study on the Efficacy and Safety of Bacterial Lysate (OM-85) Combined With Antihistamines in the Treatment of Chronic Spontaneous Urticaria (CSU): A Single-Centre, Observational, Cohort Study

    Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Phase: . Conditions: Chronic Spontaneous Urticaria (CSU)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07052903: TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Sponsor: Alnylam Pharmaceuticals. Phase: PHASE3. Conditions: Transthyretin Amyloidosis With Cardiomyopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04027868: Genomic BRCA and Extensive ovArian Cancer Testing

    Sponsor: ARCAGY/ GINECO GROUP. Phase: . Conditions: Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05855668: Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Alcohol Use Disorder, Cannabis Use Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03883217: Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

    Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03048240: INtraoperative photoDYnamic Therapy of GliOblastoma

    Sponsor: University Hospital, Lille. Phase: NA. Conditions: Glioblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06479174: Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke

    Sponsor: University of New Mexico. Phase: NA. Conditions: Stroke, Ischemic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07242118: Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management

    Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Breast Cancer Female

    full page →ctgov ↗
    ← prev
    page 13 of 98
    next →